MedPath

Repetitive Transcranial Magnetic Stimulation Versus Botulinum Injection on Spasticity on Children With Diplegic Cerebral Palsy

Not Applicable
Conditions
Spastic Diplegic Cerebral Palsy
Interventions
Device: Transcranial Magnetic Stimulation
Other: Rehabilitation Training Protocol
Registration Number
NCT06218316
Lead Sponsor
MTI University
Brief Summary

This trial will enroll 75 children with spastic diplegic cerebral palsy both matched in age, sex, degree of disability and cognitive functions with the same exclusion criteria undergoing the same physical therapy. All enrolled children will undergo routine physical therapy program and will be divided into three groups (n = 25 per group) according treatment methods. Group A: children will be given local injections of botulinum toxin type ,Group B: children will be given repetitive transcranial magnetic stimulation on the affected side; Group C: children will be given local injections of botulinum toxin type A combined with repetitive transcranial magnetic stimulation , the three groups will take physical therapy (PT) of 45 minutes duration 4 days a week for 3 months .The grade of spasticity will be assessed by using Modified Ashworth scale and M/H ratio by using EMG. The grade of motor function will assessed by using Gross Motor Function Classification System (GMFCS).

Detailed Description

This trial will enrol 75 children with spastic diaplegic cerebral palsy with both sex, degree of disability and cognitive functions with the same exclusion criteria and the same physical therapy program. All enrolled children will undergo routine physical therapy program and will be divided into three groups (n = 25 per group) according treatment methods. Group A: children will be given local injections of botulinum toxin type ,Group B: children will be given repetitive transcranial magnetic stimulation on the affected side; Group C: children will be given local injections of botulinum toxin type A combined with repetitive transcranial magnetic stimulation , the three groups will take physical therapy (PT) of 45 minutes duration 4 days a week for 3 months.

They will diagnosed based on history taking including perinatal, developmental, and family history, general and neurological examination. The included children with clinical diagnosis of moderate spastic diplegic cerebral palsy with a MAS (1, 1+, 2) and GMFCS (II, III, IV) will participated in this study. On the contrary, children with dyskinetic CP, mental retardation, previous ankle or knee surgery, uncontrolled epileptic seizure or contracture will excluded

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
75
Inclusion Criteria
  • were diagnosed based on history taking including perinatal, developmental, and family history, general and neurological examination.

The included children with clinical diagnosis of moderate spastic dialogic cerebral palsy with a MAS (1, 1+, 2) and GMFCS (II, III, IV) were participated in this study

Exclusion Criteria

Children who's contraindicated to rTMS treatment have metal implants such as internal pacemakers and intracranial scaffolds, and/or a history of epilepsy.

  • Children who's Contraindicated for BTX-A treatment: hypersensitivity and local infection at the injection site.
  • Children which have received a local injection of BTX-A within 3 months.
  • Children with dyskinetic CP,
  • Mental retardation,
  • previous, seizure or contracture were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Botox combined with transcranial magnetic stimulation for spasticityRehabilitation Training ProtocolBotox combined with transcranial magnetic stimulation for spasticity in cerebral palsy children
Botox for spasticityRehabilitation Training ProtocolBotox for spasticity in lower limbs in cerebral palsy children
transcranial magnetic stimulation for spasticityTranscranial Magnetic Stimulationtranscranial magnetic stimulation for spasticity in cerebral palsy children
transcranial magnetic stimulation for spasticityRehabilitation Training Protocoltranscranial magnetic stimulation for spasticity in cerebral palsy children
Botox combined with transcranial magnetic stimulation for spasticityTranscranial Magnetic StimulationBotox combined with transcranial magnetic stimulation for spasticity in cerebral palsy children
Botox for spasticitybotulinum toxin ABotox for spasticity in lower limbs in cerebral palsy children
Botox combined with transcranial magnetic stimulation for spasticitybotulinum toxin ABotox combined with transcranial magnetic stimulation for spasticity in cerebral palsy children
Primary Outcome Measures
NameTimeMethod
modified aswthor scale3 months

Modified Ashworth Scale (MAS): The MAS measures the resistance and spasticity in the joint during passive movement. The resistance is scored from 0 to 5 (0 the least severe to 5 the most severe

Secondary Outcome Measures
NameTimeMethod
Gross Motor Function Classification System3 months

Gross Motor Function Classification System (GMFCS): The GMFCS provides a standardized system to classify the gross motor function of children with CP into five levels (level I the least severe to level V the most severe)

Trial Locations

Locations (1)

faculty of pysical therapy, MTI university

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath